Teleperformance SE (XPAR:TEP)

€ 109.65 0.05 (0.05%) Market Cap: 6.53 Bil Enterprise Value: 10.98 Bil PE Ratio: 10.77 PB Ratio: 1.57 GF Score: 89/100

Full Year 2023 Teleperformance SE Earnings Call Transcript
Mar 07, 2024

€85.98 (-23.13%)

Earnings
Q3 2023 Teleperformance SE Corporate Sales Call Transcript
Nov 06, 2023
Half Year 2023 Teleperformance SE Earnings Call Transcript
Jul 26, 2023

€158.1 (-0.25%)

Earnings
Teleperformance SE to discuss the Proposed Acquisition of Majorel Group Luxembourg SA Presentation Transcript
Apr 26, 2023
Q1 2023 Teleperformance SE Corporate Sales Call Transcript
Apr 25, 2023
Teleperformance SE Annual Shareholders Meeting Transcript
Apr 13, 2023
Full Year 2022 Teleperformance SE Earnings Call Transcript
Feb 16, 2023

€262.6 (-0.30%)

Earnings
Teleperformance SE Exits the Highly Egregious Part of the Trust and Safety Transcript
Nov 17, 2022
Teleperformance SE Information Meeting With the Employee Representatives at TP Board Transcript
Nov 15, 2022
Teleperformance SE Information Meeting With the Management and Experts Transcript
Nov 14, 2022
Teleperformance SE to Discuss Launch of a Share Buyback Program Call Transcript
Nov 10, 2022
Q3 2022 Teleperformance SE Corporate Sales Call Transcript
Nov 04, 2022
Teleperformance SE acquires PSG Global Solutions Transcript
Oct 27, 2022
Half Year 2022 Teleperformance SE Earnings Call Transcript
Jul 27, 2022

€331.1 (+1.13%)

Earnings
Q1 2022 Teleperformance SE Corporate Sales Call Transcript
Apr 19, 2022
Teleperformance SE Annual Shareholders Meeting Transcript
Apr 14, 2022
Full Year 2021 Teleperformance SE Earnings Call Transcript
Feb 17, 2022

€315 (-0.54%)

Earnings
Teleperformance SE Acquired Senture LLC Call Transcript
Jan 03, 2022
Q3 2021 Teleperformance SE Corporate Sales Call Transcript
Nov 03, 2021
Half Year 2021 Teleperformance SE Earnings Call Transcript
Jul 28, 2021

€353.8 (-0.51%)

Earnings
Teleperformance SE Annual Shareholders Meeting Transcript
Apr 22, 2021
Q1 2021 Teleperformance SE Corporate Sales Call Transcript
Apr 12, 2021
Full Year 2020 Teleperformance SE Earnings Call Transcript
Feb 25, 2021

€274.1 (+0.04%)

Earnings
Q3 2020 Teleperformance SE Corporate Sales Call Transcript
Nov 03, 2020
Teleperformance SE To Discuss The Agreement to Acquire Health Advocate from Intrado Corporation Call Transcript
Oct 27, 2020
Half Year 2020 Teleperformance SE Earnings Call Transcript
Jul 29, 2020

€237.2 (-0.59%)

Earnings
Teleperformance SE Annual Shareholders Meeting (English, French) Transcript
Jun 26, 2020
Q1 2020 Teleperformance SE Corporate Sales Call Transcript
Apr 28, 2020
Full Year 2019 Teleperformance SE Earnings Presentation Transcript
Feb 21, 2020
Q3 2019 Teleperformance SE Corporate Sales Call Transcript
Nov 04, 2019
Teleperformance SE Digital Day Transcript
Oct 16, 2019
Half Year 2019 Teleperformance SE Earnings Call Transcript
Jul 25, 2019

€180 (-0.66%)

Earnings
Q1 2019 Teleperformance SE Corporate Sales Call Transcript
Apr 24, 2019
Full Year 2018 Teleperformance SE Earnings Presentation Transcript
Mar 01, 2019

Teleperformance SE To Discuss The Agreement to Acquire Health Advocate from Intrado Corporation Call Transcript

Oct 27, 2020 / 05:13PM GMT

Release Date Price: €254.7 (-1.13%)

Transcript

Operator

Hello, and welcome to today's call on Teleperformance's agreement to acquire Health Advocate. My name is Courtney, and I'll be your coordinator for today's event. Please note that this conference is being recorded. (Operator Instructions) And I will now hand you over to your host, Daniel Julien, Chairman and CEO of Teleperformance to begin today's conference. Thank you.

Daniel Julien

Teleperformance SE - Executive Chairman & Global CEO

Thank you. Good evening, or good morning for the one who are in the U.S. I'm very, very happy tonight to present to this group, the brand-new Teleperformance signing of Health Advocate. In fact, with Health Advocate, we continue to strengthen our footprint on the U.S. health care market. Health Advocate is a highly sophisticated service company that helps something like 27 million employees of its 8,400 clients to navigate the U.S. health care system. And everybody knows it's amazing. So both Health Advocate help at the administrative level and at the clinical level, and with a mix of health experts, whether in benefits or in

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.